Skip to main content
Premium Trial:

Request an Annual Quote

Fulgent Genetics: Brandon Perthuis

Fulgent Genetics has promoted Brandon Perthuis to chief commercial officer from VP of commercial operations. He will continue to lead the company's global sales organization and commercialization effort and will report to CEO Ming Hsieh. Perthuis came to Fulgent in 2017. He carries 16 years of experience in clinical genetics, including a stint as VP of sales and marketing at Baylor Genetics.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.